LIGAND UK DEVELOPMENT LIMITED
- Legal registered address
- Suite 1, 7th Floor 50 Broadway London United Kingdom SW1H 0DB Copied!
- Company number
- 02600483 Copied!
Accounts
Latest annual accounts were to 30 December 2023
Next annual accounts are due by 30 September 2025
Company financial year end is on 30 December 2025
Confirmation statement
Latest confirmation statement statement dated 30 September 2024
Next statement due by 14 October 2025
Nature of business (SIC)
21100 - Manufacture of basic pharmaceutical products
21200 - Manufacture of pharmaceutical preparations
72110 - Research and experimental development on biotechnology
Previous company names
| Name | Date previous name changed |
|---|---|
| VANGUARD MEDICA LIMITED | 19 May 2000 |
| VERNALIS LIMITED | 1 October 2003 |
| VERNALIS DEVELOPMENT LIMITED | 3 December 2020 |
Latest company documents
| Date | Description |
|---|---|
| 15/04/2515 April 2025 | Full accounts made up to 2023-12-30 |
| 08/04/258 April 2025 | Termination of appointment of Matthew Edward Korenberg as a director on 2024-10-15 |
| 03/10/243 October 2024 | Confirmation statement made on 2024-09-30 with no updates |
| 23/05/2423 May 2024 | Change of details for Ligand Holdings Uk Ltd. as a person with significant control on 2024-04-10 |
| 10/04/2410 April 2024 | Registered office address changed from C/O Legalinx Limited 3rd Floor 207 Regent Street London W1B 3HH United Kingdom to Suite 1, 7th Floor 50 Broadway London SW1H 0DB on 2024-04-10 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company